RESMED, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 184.2 USD | +2.16% |
|
+5.99% | +7.11% |
| Apr. 17 | Wall St set for higher open on megacaps boost; earnings, Fed comments on tap | RE |
| Apr. 01 | Needham Adjusts ResMed's Price Target to $224 From $180, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
2024-04-25
- Q3 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
180.4
USD
Average target price
206.1
USD
Spread / Average Target
+14.25%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.11% | 26.49B | |
| +8.35% | 209B | |
| +9.41% | 175B | |
| +11.75% | 131B | |
| +19.34% | 99.98B | |
| -0.84% | 61.12B | |
| +15.08% | 52.34B | |
| -2.10% | 46.5B | |
| +0.10% | 39.24B | |
| +11.50% | 38.47B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Insider Trends: 90-Day Insider Buying Trend at ResMed Interrupted with Sale of Shares
